Ordinary Index Rebalancing in the Solactive Pharma & Biotech Opportunity Index | November 2020

In the ordinary rebalance the following composition will be implemented effective open 19.11.2020:

3SBIO INC
ABCAM PLC
AGIOS PHARMACEUTICALS INC
ALKERMES PLC
ARGENX SE
BIOMARIN PHARMACEUTICAL INC
BLUEBIRD BIO INC
CHINA BIOLOGIC PRODUCTS HOLD
CORCEPT THERAPEUTICS INC
CSPC PHARMACEUTICAL GROUP LTD
DECHRA PHARMACEUTICALS PLC
EMERGENT BIOSOLUTIONS INC
EXELIXIS INC
GALAPAGOS NV
GENEXINE CO LTD
HANMI PHARM CO LTD
HANMI SCIENCE CO LTD
HORIZON THERAPEUTICS PLC
IONIS PHARMACEUTICALS INC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
MORPHOSYS AG
NEKTAR THERAPEUTICS
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT.
SANTEN PHARMACEUTICAL CO LTD ORD
SAWAI PHARMACEUTICAL CO LTD ORD
SINO BIOPHARMACEUTICAL LTD ORD
SWEDISH ORPHAN BIOVITRUM AB
VIFOR PHARMA AG
XENCOR INC